Position in ABBV
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$17,376,245
+$10,520,743 QoQ
Shares Held
69,052
+119.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#672
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MISSION WEALTH MANAGEMENT, LP holds $105,799,986 across 14 Drug Manufacturers - General names. ABBV ranks #3 (16.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
25,625 | $30,735,396 | |
| 2 | JNJ |
Johnson & Johnson
|
96,816 | $24,588,359 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
69,052 | $17,376,245 | |
| 4 | MRK |
Merck & Co., Inc.
|
72,281 | $9,288,108 | |
| 5 | AMGN |
Amgen Inc
|
25,436 | $9,210,884 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
59,419 | $3,423,722 | |
| 7 | NVS |
Novartis AG
|
19,690 | $3,085,816 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
16,879 | $2,132,492 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,376,245 | 69,052 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $6,855,502 | 31,521 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,514,451 | 37,264 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $10,850,195 | 46,861 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $8,873,935 | 47,807 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $10,060,940 | 48,019 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $8,485,708 | 47,753 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $9,228,832 | 46,733 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $6,865,774 | 40,029 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $7,439,331 | 40,853 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $5,809,360 | 37,487 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $5,258,687 | 35,279 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $4,755,834 | 35,299 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $5,350,688 | 33,574 | Shares | Sole | 2023-04-07 | |
| 2022-12-31 | $5,740,387 | 35,520 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $4,214,999 | 31,406 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $4,485,290 | 29,285 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $4,936,411 | 30,451 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $2,588,171 | 19,115 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,999,801 | 18,539 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $2,144,102 | 19,035 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,178,685 | 20,132 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,937,914 | 18,086 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $1,648,881 | 18,825 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $1,781,181 | 18,142 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $1,167,764 | 15,327 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||